Ten-year follow up from the CheckMate 067 and KEYNOTE-006 trials confirm that patients with advanced melanoma can achieve durable responses from treatment with the PD1 inhibitors nivolumab and pembrolizumab and that a lack of disease progression at 3 years is strong indicator of long-term survival.
2024
50 million for innovative research into mental health, melanoma and more
The search for a multi-season flu vaccine, better treatment for schizophrenia, and how gut microorganisms may fight off melanoma, are 3 projects sharing in $50 million in health research funding from the Australian Government.
Survival Plateau Observed After ICI Therapy in Advanced Melanoma
Patients with advanced melanoma reach a plateau in survival after treatment with immune checkpoint inhibitors (ICIs), according to real-world data published in JAMA Network Open.
Trial of personalised immunotherapy cancer treatment shows promise on melanoma
David Braund went to his GP in April with a small pimple-like mark on his forehead and a swollen lymph node.